Department of Gastrointestinal Surgery, Zhongnan Hospital of Wuhan University, Wuhan, China.
Department of Gastric and Colorectal Surgical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Clin Transl Med. 2021 Dec;11(12):e595. doi: 10.1002/ctm2.595.
Metastasis is the main cause of death in colorectal cancer (CRC). Circulating tumour cells (CTCs) are regarded as the precursor cells of metastasis. The CTCs, which underwent epithelial-mesenchymal transition (EMT), are associated with metastasis and responsible for poor prognosis. EMT cancer cells modulate endothelial permeability in the invasive front and facilitate cancer cell intravasation, resulting in CTCs-mediated distant metastasis. Exosomes derived from cancer cells are key mediators of cancer-host intercommunication. However, the mechanism by which EMT-tumour cells-derived exosomes modulate vascular permeability and promote CTCs generation has remained unclear.
Exosomes isolation and purification were conducted by ultra-centrifugation. Exosomal miRNA was identified by sequencing followed by quantitative PCR. In vitro co-culture assay experiments were conducted to evaluate the effect of exosomal miR-27b-3p on the permeability of blood vessel endothelium. Dual-luciferase reporter assay, chromatin immunoprecipitation (ChIP) and RNA immunoprecipitation (RIP) were performed to investigate the underlying mechanism by which miR-27b-3p is packaged into exosomes. A mouse model was established to determine the role of exosomal miR-27b-3p in blood vessel permeability modulation in vivo.
We found that EMT-CRC cells attenuate the blood vessel barrier by transferring miR-27b-3p to human umbilical vein endothelial cells (HUVECs) in exosomes. Mechanically, miR-27b-3p atteuated the expression of vascular endothelial cadherin (VE-Cad) and p120 at the post-transcriptional level by binding to 3'-untranslated region of VE-Cad and p120 directly. The packaging of miR-27b-3p into exosomes was induced by heterogeneous nuclear ribonucleoprotein A1 (hnRNPA1), which activated by STAT3. Clinically, miR-27b-3p up-regulated in CRC tissues. Plasma exosomal miR-27b-3p was positively correlated with malignant progression and CTC count in CRC patients. Our study reveals a novel mechanism by which EMT-CRC cells promote metastasis, increasing blood vessel permeability and facilitating the generation of CTCs.
Exosomal miR-27b-3p secreted by EMT-CRC cells increases blood vessel permeability and facilitates the generation of CTCs. Exosomal miR-27b-3p may become a promising biomarker for CRC metastasis.
转移是结直肠癌(CRC)死亡的主要原因。循环肿瘤细胞(CTC)被认为是转移的前体细胞。经历上皮-间充质转化(EMT)的 CTC 与转移有关,并导致预后不良。EMT 癌细胞在侵袭前沿调节血管通透性,并促进癌细胞浸润,从而导致 CTC 介导的远处转移。源自癌细胞的外泌体是癌症-宿主相互交流的关键介质。然而,EMT 肿瘤细胞衍生的外泌体如何调节血管通透性并促进 CTC 产生的机制尚不清楚。
通过超速离心分离和纯化外泌体。通过测序和定量 PCR 鉴定外泌体中的 miRNA。体外共培养实验评估外泌体 miR-27b-3p 对血管内皮通透性的影响。双荧光素酶报告基因实验、染色质免疫沉淀(ChIP)和 RNA 免疫沉淀(RIP)实验用于研究 miR-27b-3p 被包装到外泌体中的潜在机制。建立小鼠模型以确定外泌体 miR-27b-3p 在体内调节血管通透性中的作用。
我们发现 EMT-CRC 细胞通过外泌体将 miR-27b-3p 转移到人脐静脉内皮细胞(HUVEC)中,从而减弱血管屏障。在机制上,miR-27b-3p 通过直接结合 VE-Cad 和 p120 的 3'-非翻译区,在转录后水平下调 VE-Cad 和 p120 的表达。miR-27b-3p 的包装由异质核核糖核蛋白 A1(hnRNPA1)诱导,hnRNPA1 由 STAT3 激活。临床上,CRC 组织中 miR-27b-3p 上调。CRC 患者血浆外泌体 miR-27b-3p 与恶性进展和 CTC 计数呈正相关。我们的研究揭示了 EMT-CRC 细胞促进转移的新机制,增加血管通透性并促进 CTC 的产生。
EMT-CRC 细胞分泌的外泌体 miR-27b-3p 增加血管通透性并促进 CTC 的产生。外泌体 miR-27b-3p 可能成为 CRC 转移有前途的生物标志物。